Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis

Company Overview

Carl Zeiss Meditec AG is a Germany-based medical technology company focused on ophthalmology and microsurgery. The company develops, manufactures and distributes diagnostic and therapeutic systems, surgical equipment, implants and related digital solutions for healthcare professionals.

Its ophthalmic portfolio includes devices for eye examinations and diagnostics, laser systems for refractive and cataract procedures, surgical microscopes, intraocular lenses and other products used in cataract, retinal, glaucoma and corneal treatments. The company also supplies visualization systems and surgical microscopes for microsurgical procedures in areas such as neurosurgery, spine surgery and ear, nose and throat surgery.

Carl Zeiss Meditec was established in 2002 through the combination of the ophthalmology activities of Carl Zeiss and Asclepion-Meditec. Headquartered in Jena, Germany, the company serves hospitals, clinics, ophthalmic practices and surgeons worldwide through its international sales and service organization. Markus Weber has served as the company’s chief executive officer since 2020.

Key Stats

• Today's Range: $36.54 to $36.86
• 50-Day Range: $33.27 to $37.96
• 52-Week Range: $26.65 to $55.94
• Volume: 102 shs
• Average Volume: 4,134 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Sell

Carl Zeiss Meditec Stock Analysis - MarketRank™

Carl Zeiss Meditec scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Strong Sell

Consensus Rating

Carl Zeiss Meditec has received a consensus rating of Strong Sell. The company's average rating score is 1.40, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 3 sell ratings.

Amount of Analyst Coverage

Carl Zeiss Meditec has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 18.90%

Earnings Growth

Earnings for Carl Zeiss Meditec are expected to grow by 18.90% in the coming year, from $1.27 to $1.51 per share.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Carl Zeiss Meditec has a short interest ratio ("days to cover") of 0.23, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Carl Zeiss Meditec has recently increased by 126.25%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Carl Zeiss Meditec does not currently pay a dividend.

Dividend Growth

Carl Zeiss Meditec does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.33

News Sentiment

Carl Zeiss Meditec has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Carl Zeiss Meditec this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock.

Percentage Held by Institutions

Carl Zeiss Meditec has minimal institutional ownership at this time.

Company Calendar

• Today: 10/12/2026
• Next Earnings (Estimated): 12/10/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CZMWY
• CIK: N/A
• Web: www.zeiss.com
• Phone: 493641220115
• Fax: N/A
• Employees: 5,784
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A